StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
This year
3
Publishing Date
2024 - 03 - 28
1
2024 - 03 - 15
1
2024 - 01 - 15
1
2023 - 12 - 07
1
2023 - 01 - 06
1
2022 - 05 - 25
1
2022 - 05 - 17
1
2022 - 03 - 18
1
Sector
Health technology
8
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Abbvie inc.
4
Abcam plc
1
Amgen inc.
3
Astrazeneca plc
1
Biogen inc.
1
Bristol-myers squibb company
1
Eli lilly and company
4
Glaxosmithkline plc
2
Immunome, inc.
1
Immutep limited
1
Johnson & johnson
4
Novartis ag
8
Regeneron pharmaceuticals, inc.
2
Sanofi
3
Takeda pharmaceutical company limited
3
Symbols
ABBV
17
ABCL
15
ABCM
20
ABCZF
13
ADAG
12
AGEN
7
ALPMF
6
ALPMY
6
AMGN
10
ANAB
5
APVO
8
ARDS
6
AXIM
8
AZN
19
AZNCF
6
BGNE
5
BIIB
9
BIO
7
BMY
14
BNTX
5
CGEN
8
CMMB
5
CRBP
7
DHR
5
FSTX
8
GMAB
11
GNMSF
11
GSK
9
IGMS
11
IMAB
37
IMGN
5
IMMP
5
IMNM
11
INCY
18
IPA
20
JNJ
44
KA
6
LIFE
6
LLY
51
MRNA
5
NVS
13
NVSEF
8
OCDX
7
PFE
7
PKI
6
REGN
14
SNSE
10
SNY
65
SNYNF
48
SRNE
23
STRO
8
TAK
7
TLSA
11
TMO
7
TNXP
6
TWST
24
VIR
7
VYGR
6
XNCR
13
ZYME
7
Exchanges
Nasdaq
8
Nyse
8
Crawled Date
2024 - 03 - 28
1
2024 - 03 - 15
1
2024 - 01 - 15
1
2023 - 12 - 07
1
2023 - 01 - 06
1
2022 - 05 - 25
1
2022 - 05 - 17
1
2022 - 03 - 18
1
Crawled Time
04:00
1
11:00
1
12:30
1
14:30
1
15:30
2
17:00
1
20:00
1
Source
www.globenewswire.com
1
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Antibody
symbols :
NVSEF
save search
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-7.26%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
-3.52%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.295
0.95%
0.0%
11M
|
Health Technology
|
-9.37%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-6.76%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-8.3%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.15%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-9.96%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
-1.31%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$164.69
0.27%
0.0%
4.5M
|
Health Technology
|
-9.09%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-4.79%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
-6.03%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-1.7%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published:
2024-01-15
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-12.55%
|
O:
-2.03%
H:
0.05%
C:
0.05%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-13.37%
|
O:
0.16%
H:
0.43%
C:
0.07%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
16.78%
|
O:
0.15%
H:
0.59%
C:
-1.45%
ABBV
|
$164.69
0.27%
0.0%
4.5M
|
Health Technology
|
0.7%
|
O:
-0.49%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-11.95%
|
O:
-1.34%
H:
0.0%
C:
0.0%
investments
report
antibody
reach
research
global
growth
market
Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published:
2023-12-07
(Crawled : 15:30)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
0.64%
|
O:
-1.66%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-4.09%
|
O:
-0.97%
H:
0.3%
C:
-0.19%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-8.68%
|
O:
-1.61%
H:
0.0%
C:
0.0%
ABBV
|
$164.69
0.27%
0.0%
4.5M
|
Health Technology
|
13.1%
|
O:
1.97%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.35%
|
O:
-1.19%
H:
0.0%
C:
0.0%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
7.83%
|
O:
0.51%
H:
1.22%
C:
1.09%
IMNM
|
$17.175
-1.18%
-1.19%
850K
|
Health Technology
|
121.68%
|
O:
-0.64%
H:
1.67%
C:
-1.16%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-16.56%
|
O:
1.67%
H:
0.91%
C:
0.57%
antibody
therapeutics
market
Antibody Drug Conjugate Global Market Report 2023: Featuring Seattle Genetics, F. Hoffman-La Roche, ImmunoGen, Bayer & More
Published:
2023-01-06
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
TAK
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-14.72%
|
O:
0.13%
H:
1.33%
C:
0.91%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
2.51%
|
O:
0.35%
H:
1.43%
C:
1.28%
drug
global
report
antibody
market
Anti-CD20 Monoclonal Antibodies (mABs) Market size to increase by USD 9.05 Bn | 9.0% YOY growth expected in 2022 | Technavio
Published:
2022-05-25
(Crawled : 04:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
2.15%
|
O:
-1.42%
H:
2.73%
C:
2.73%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
24.44%
|
O:
0.89%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
2.15%
|
O:
0.29%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
2.27%
|
O:
-0.45%
H:
0.89%
C:
0.54%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
7.01%
|
O:
1.42%
H:
0.72%
C:
0.0%
cd20
expected
growth
market
antibody
Monoclonal Antibodies Market to hit USD 425 Billion by 2028, Says Global Market Insights Inc.
Published:
2022-05-17
(Crawled : 11:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-25.87%
|
O:
-0.92%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
29.87%
|
O:
0.55%
H:
0.0%
C:
0.0%
TAK
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-7.78%
|
O:
0.21%
H:
0.42%
C:
0.14%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
7.35%
|
O:
1.63%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-18.15%
|
O:
1.08%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-9.63%
|
O:
1.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
154.61%
|
O:
1.74%
H:
1.13%
C:
0.47%
ABBV
|
$164.69
0.27%
0.0%
4.5M
|
Health Technology
|
6.21%
|
O:
0.46%
H:
0.0%
C:
0.0%
market
antibody
Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525
Published:
2022-03-18
(Crawled : 12:30)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
12.78%
|
O:
1.11%
H:
0.0%
C:
0.0%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
9.6%
|
O:
1.17%
H:
1.2%
C:
1.01%
IMMP
|
News
|
$2.205
-2.43%
-2.73%
270K
|
Health Technology
|
-16.91%
|
O:
3.31%
H:
11.74%
C:
10.32%
lag525
patent
antibody
grant
granted
Gainers vs Losers
66%
34%
Top 10 Gainers
AGBA
|
$1.02
155.0%
60.78%
120M
|
Finance
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
$0.92
84.0%
45.65%
900K
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
ZCMD
|
$2.44
78.1%
43.85%
330K
|
Commercial Services
XPON
|
$3.1
60.62%
37.74%
16M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.